Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme

被引:20
作者
Cheng, J
Luo, JY
Zhang, XY
Hu, JL
Hui, HX
Wang, CJ
Stern, A
机构
[1] NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA
[2] Xian Med Univ, Coll 2, Inst Gastroenterol, Xian, Peoples R China
[3] Fourth Mil Med Univ, Xijing Hosp, Inst Gastroenterol, Xian, Peoples R China
[4] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian, Peoples R China
关键词
hepatoma cells; ribozyme; c-myc; retroviral vector;
D O I
10.1038/sj.cgt.7700127
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A ribozyme (RZ) gene targeting c-myc mRNA was synthesized and cloned. Cleavage reaction showed that cleavage of the RZ was efficient and specific. The RZ gene-containing retrovirus vector pDOR-RZ was transfected into HCC-9204 hepatoma cells, which constitutively express high levels of c-myc using Lipofectamine. Positively transfected cells were selected using G418. In situ hybridization showed that both pDOR-RZ and pDOR vectors had been integrated into the chromosome of HCC-9204 cells. Dot blot hybridization indicated that expression of the RZ was only evident in pDOR-RZ-transfected HCC-9204 cells. Avidin-biotin complex enzyme-linked immunosorbent assay showed that c-myc expression was down-regulated. Chromatin aggregation into compact masses, cytoplasmic vacuole degeneration, and blurring of cytoplasm structure were observed by transmission electron microscopy in HCC-9204-RZ cells. These results suggest that the use of a c-myc mRNA cleaving enzyme could be most effective in tumor cells that are highly proliferative and constitutively express high levels of c-myc.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 31 条
[1]  
ALLA D, 1996, CANCER GENE THER, V3, P289
[2]   Colocalization of antisense RNAs and ribozymes with their target mRNAs [J].
Arndt, GM ;
Rank, GH .
GENOME, 1997, 40 (06) :785-797
[3]   THE CHEMISTRY OF SELF-SPLICING RNA AND RNA ENZYMES [J].
CECH, TR .
SCIENCE, 1987, 236 (4808) :1532-1539
[4]   A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines [J].
Chang, MY ;
Won, SJ ;
Liu, HS .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (02) :91-99
[5]   RIBOZYMES AS HUMAN THERAPEUTIC AGENTS [J].
CHRISTOFFERSEN, RE ;
MARR, JJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) :2023-2037
[6]  
Dorai T, 1997, ANTICANCER RES, V17, P3307
[7]   Ribozymes - Their functions and strategies for their use [J].
Gibson, SA ;
Shillitoe, EJ .
MOLECULAR BIOTECHNOLOGY, 1997, 7 (02) :125-137
[8]   ANTISENSE MYC SEQUENCES INDUCE DIFFERENTIATION OF F9 CELLS [J].
GRIEP, AE ;
WESTPHAL, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6806-6810
[9]   Proteins of the Myc network: Essential regulators of cell growth and differentiation [J].
Henriksson, M ;
Luscher, B .
ADVANCES IN CANCER RESEARCH, VOL 68, 1996, 68 :109-182
[10]   AN OLIGOMER COMPLEMENTARY TO C-MYC MESSENGER-RNA INHIBITS PROLIFERATION OF HL-60 PROMYELOCYTIC CELLS AND INDUCES DIFFERENTIATION [J].
HOLT, JT ;
REDNER, RL ;
NIENHUIS, AW .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :963-973